Antonio Moschetta is funded by Italian Association for Cancer Research (AIRC, IG 18987), MIUR PRIN 2017J3E2W2_002, JPI-EU FATMAL
However, if cold intolerance is severe, persistent, or accompanied by other concerning symptoms, further clinical evaluation is warranted to exclude alternative causes
Phase-specific tables with exact syringe markings for every dose at every common reconstitution volume
Several trials with tirzepatide are also ongoing, including SURPASS-6, SURPASS-J, SURPASS-AP, and SURPASS-CVOT, all of which will look at the effects of this agent compared to other agents (insulin lispro, dulaglutide, insulin glargine) on weight, HbA1c, and the occurrence of major adverse cardiovascular events (MACE), respectively [38]